Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Melanotan-I

Afamelanotide, MT-I, [Nle4-D-Phe7]-α-MSH, Scenesse, CUV-1647

Quick Stats
Studies 225
Trials 100
Score 2
1983 pubmed 25 citations

Behavioral effects of [4-norleucine, 7-D-phenylalanine]-alpha-melanocyte-stimulating hormone.

Kobobun. K K; O'Donohue. T L TL; Handelmann. G E GE; Sawyer. T K TK; Hruby. V J VJ; Hadley. M E ME

Key Findings

  • Melanotan‑I is equally effective as alpha‑MSH at inducing grooming when given directly into the brain
  • Unlike alpha‑MSH, melanotan‑I reduces performance on a visual discrimination (learning) task
  • The peptide likely acts as an antagonist at CNS melanocortin receptors that support learning and attention

Practical Outcomes

  • If you’re using melanotan‑I for skin tanning or other purposes, be aware it may impair cognitive tasks that require focus and learning. It doesn’t appear to boost mental performance and could be counter‑productive for anyone seeking cognitive or physical performance gains. Use with caution, especially before activities that demand sharp attention.

Summary

The study shows that melanotan‑I (a modified alpha‑MSH) triggers the same grooming behavior as the natural hormone but actually worsens performance on a visual learning test, suggesting it might block brain receptors involved in attention and memory.

Abstract

The behavioral effects of alpha-melanocyte stimulating hormone (alpha-MSH) were compared to an alpha-MSH analogue that had a norleucine substituted for methionine in the four position and a D-phenylalanine substituted for L-phenylalanine in the seven position. [Nle4, D-Phe7]-alpha-MSH has previously been shown to be a superpotent agonist on melanocytes [17]. The present experiments indicate that [Nle4, D-Phe7]-alpha-MSH is equipotent to alpha-MSH in inducing grooming when administered intraventricularly. In contrast, the analogue has the opposite effect of alpha-MSH on performance of a visual discrimination task. alpha-MSH improves visual performance whereas [Nle4, D-Phe7]-alpha-MSH attenuates such performance. The contrasting activities of [Nle4, D-Phe7]-alpha-MSH on the physiological processes described suggest that this analogue may interact with three distinct melanotropin receptors in different ways. On melanocyte receptors the melanotropin analogue is a superagonist, on CNS melanotropin receptors involved in grooming it is equipotent to alpha-MSH, and on CNS receptors involved in attention, learning and memory [Nle4, D-Phe7]-alpha-MSH may be an antagonist of endogenous melanotropin.

Study Information

Provider

pubmed

Year

1983

Date

1983-09-01T00:00:00.000Z

DOI

10.1016/0196-9781(83)90025-6

Citations

25

References

16